Afteradjusting for clinical predictors and biomarkers (hs-cTnT, NTproBNP, hs-CRP, andcystatin C), the study showed that elevated GDF-15 levels were associated with anincreased risk of, CV mortality, myocardial infarction, and stroke [40]. This evidence concerns the gene GDF15 and stroke disorder.